FIND A BIOALPS ACTOR
Esperare

EspeRare gains rights to relaunch late stage development for a rare genetic disease

26.04.2018
Share this article
EspeRare is delighted to announce that it has concluded an important agreement with Edimer Pharmaceuticals.